Meissa Vaccines’ leg up in the Covid-19 vaccines chase goes through the nose

An intranasal Covid-19 vaccine candidate from Meissa Vaccines could offer advantages compared to injectable ones. The company is still in early clinical development but the company now has data from monkey studies that further build the case for the vaccine.